Matteo Grioni

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.

Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.

Journal: Cancer research
Published: June 25, 2025

A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

Journal: Cancer discovery
Published: June 24, 2025

Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma.

Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma.

Journal: Nature communications
Published: December 26, 2023

Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis.

Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis.

Journal: Science (New York, N.Y.)
Published: October 07, 2021

[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma.

[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma.

Journal: Frontiers in oncology
Published: August 18, 2021

CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism.

CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism.

Journal: Blood advances
Published: November 09, 2020

Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer.

Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer.

Journal: Frontiers in immunology
Published: May 25, 2020

Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.

Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.

Journal: Frontiers in immunology
Published: March 05, 2020

Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression.

Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression.

Journal: Cell reports
Published: October 04, 2017

Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy.

Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 29, 2017

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression.

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression.

Journal: Nature communications
Published: May 10, 2017

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors.

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors.

Journal: Cancer research
Published: March 08, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026